Citadel Advisors Llc - Jul 9, 2025 SCHEDULE 13G Report for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ALLO)

Filing Manager
Citadel Advisors Llc
Reporting Manager
Kenneth Griffin
Security
Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares")
Symbol
ALLO
Shares outstanding
219M shares
Disclosed Ownership
13.3M shares
Ownership
6.1%
Form type
SCHEDULE 13G
Date filed
7/16/2025, 06:02 PM
Date of event
Jul 9, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.7% 10.2M 0 10.2M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.7% 10.2M 0 10.2M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.7% 10.2M 0 10.2M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 1.4% 3.14M 0 3.14M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 1.4% 3.14M 0 3.14M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 1.4% 3.14M 0 3.14M /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 6.1% 13.3M 0 13.3M /s/ Seth Levy Seth Levy, attorney-in-fact*